# TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC

> **NCT07697898** · — · NOT_YET_RECRUITING · sponsor: **Tongji Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma (ESCC)

## Interventions

- **PROCEDURE:** Curative Esophagectomy With Systematic Lymphadenectomy

## Key facts

- **NCT ID:** NCT07697898
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697898, "TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*